Professional Documents
Culture Documents
Status Asthmaticus in Children
Status Asthmaticus in Children
HeinrichWerner
PediatricCriticalCare
UniversityofKentuckyChildrens
Hospital
hwerner
Statusasthmaticus
Objectives
Theparticipantwillincreasehis/her
Awarenessofrisingmorbidity/mortalityofsevereasthmain
children
Abilitytodefinewhoisatriskfordying
Understandingofthepathologic,metabolicandbiomechanical
events
Abilitytopredictrespiratoryfailureandtodeterminethe
needforearlytransfer
Abilitytotailorthetherapeuticregimenaccordingtoseverity
andprogressionofstatusasthmaticus
Statusasthmaticus
StatusAsthmaticusinChildren
Epidemiology
Pathophysiology
PresentationandAssessment
Treatment
Statusasthmaticus
StatusAsthmaticusinChildren
Epidemiology
Prevalence
Morbidity
Mortality
Riskfactors
Pathophysiology
Presentationandassessment
Treatment
Statusasthmaticus :Epidemiology
Prevalence
Theprevalenceofpediatricasthmainthe
USisincreasing
60
50
1975
1980-81
1985
1989
1990-92
1993-95
40
30
20
10
0
0-4 yrs
5-14 yrs
15-34 yrs
Statusasthmaticus :Epidemiology
Morbidity
Themorbidityofpediatricasthmainthe
USisincreasing
Rate per 10,000 population
70
60
50
< 1 year
1-4 years
5-14 years
15-24 years
40
30
20
10
1992
1990
1988
1986
1984
1982
1980
Statusasthmaticus :Epidemiology
Mortality
ThemortalityofpediatricasthmaintheUS
isincreasing
Rate per 1,000,000 population
7
6
5
0-4 years
5-14 years
15-34 years
4
3
2
1
0
1979-80 1981-83 1984-86 1987-89 1990-92 1993-95
Statusasthmaticus :Epidemiology
Riskfactorsforfatalasthma
Medical
Previousattackwithrapid/severedeteriorationorrespiratory
failureorseizure/lossofconsciousness
Psychosocial
Denial,noncompliance
Depressionorotherpsychiatricdisorder
Dysfunctionalfamily
Innercityresident
Ethnic
Nonwhitechild
Statusasthmaticus
StatusAsthmaticusinChildren
Epidemiology
Pathophysiology
Cytokines
Airwaypathology
Autonomicnervoussystem
Pulmonarymechanics
Cardiopulmonaryinteractions
Metabolism
Presentationandassessment
Treatment
Statusasthmaticus :Pathophysiology
Pathophysiology
Asthmaisprimarilyaninflammatorydisease
Smooth muscle
spasm
Airway edema
Mucous plugging
Statusasthmaticus :Pathophysiology
Inflammatorycytokines
Activatedmastcellsandlymphocytes
produceproinflammatorycytokines
(histamine,leukotrienes,PAF),whichare
increasedinasthmaticsairwaysand
bloodstream
Statusasthmaticus :Pathophysiology
Irritableanddamagedairway
Hypersecretion
Epithelialdamagewith
exposednerveendings
Hypertrophyofgobletcells
andmucusglands
Statusasthmaticus :Pathophysiology
Airway
Theirritableandinflamedairwayissusceptibleto
obstructiontriggeredby
Allergens
Infections
Irritantsincludingsmoke
Exercise
Emotionalstress
GEreflux
Drugs
Otherfactors
Statusasthmaticus :Pathophysiology
Autonomicnervoussystem
Bronchodilation
Sympathetic
Circulatingcatecholamines
stimulatereceptors
Parasympathetic
Vagalsignalsstimulate
bronchodilatingM2
receptors
Nonadrenergic
noncholinergic
(NANC)
Releaseofbronchodilating
neurotransmitters(VIP,NO)
Bronchoconstriction
Vagalsignalsstimulate
bronchoconstrictingM3
receptors
Releaseoftachykinins(substance
P,neurokininA)
Statusasthmaticus :Pathophysiology
Lungmechanics
Hyperinflation
Obstructedsmallairwayscausepremature
airwayclosure,leadingtoairtrappingand
hyperinflation
Hypoxemia
Inhomogeneousdistributionofaffectedareas
resultsinV/Qmismatch,mostlyshunt
Statusasthmaticus :Pathophysiology
Severeairflow
obstruction
Incomplete
exhalation
Increasedlung
volume
Increasedelastic
recoilpressure
Expandedsmall
airways
Increased
expiratoryflow
Decreasedexpiratory
resistance
Compensated:
Hyperinflation,normocapnia
Worsening
airflow
obstruction
Decompensated:
Severehyperinflation,hypercapnia
Fromtextin:
Tuxen.AmRev
RespirDis
1992;146:1136
Statusasthmaticus :Pathophysiology
Cardiopulmonaryinteractions
Leftventricularload
Spontaneouslybreathingchildrenwithsevere
asthmahavenegativeintrapleuralpressure
(aslowas35cmH2O)duringalmostthe
entirerespiratorycycle
StalcupS.NEnglJMed1977;297:5926
Negativeintrapleuralpressurecauses
increasedleftventricularafterload,resulting
inriskforpulmonaryedema
BudaAJ.NEnglJMed1979;301(9):4539
Statusasthmaticus :Pathophysiology
Cardiopulmonaryinteractions
Rightventricularload
Hypoxicpulmonaryvasoconstrictionandlung
hyperinflationleadtoincreasedright
ventricularafterload
DawsonCA.JApplPhysiol1979;47(3):5326
Statusasthmaticus :Pathophysiology
Cardiopulmonaryinteractions
Pulsusparadoxus
P.paradoxusistheclinicalcorrelateofcardiopulmonary
interactionduringasthma.Itisdefinedasexaggerationof
thenormalinspiratorydropinsystolicBP:normally<5
mmHg,but>10mmHginpulsusparadoxus.
Nl
P.paradoxus
Expir
Inspir
Expir
Inspir
Statusasthmaticus :Pathophysiology
Pulsusparadoxuscorrelateswith
severity
AllpatientswhopresentedwithFEV1of<20%
(oftheirbestFEV1whilewell)hadpulsus
paradoxus
PiersonRN.JApplPhysiol1972;32(3):3916
Statusasthmaticus :Pathophysiology
Cardiopulmonaryinteractions
Negative intrapleural
pressure
Hyperinflation
Altered hemodynamics
Pulmonary edema
Pulsus paradoxus
Hypotension
Statusasthmaticus :Pathophysiology
Metabolism
V/Q mismatch
Increased work
of breathing
Dehydration
Hypoxia
Lactate
Metabolic acidosis
Ketones
Statusasthmaticus :Presentation
Presentation
Audiblewheezes:reasonableairflow
Audiblewheezes:reasonableairflow
Cough
Silentchest:ominous!
Silentchest:ominous!
Wheezing
Increasedworkofbreathing
Anxiety
Restlessness
Oxygendesaturation
Statusasthmaticus :Assessment
Assessment
Findingsconsistentwithimpendingrespiratory
failure:
Alteredlevelofconsciousness
Inabilitytospeak
Absentbreathsounds
Centralcyanosis
Diaphoresis
Inabilitytoliedown
Markedpulsusparadoxus
Statusasthmaticus :Assessment
ClinicalAsthmaScore
0
Nl
Unequalor
Expirwheezing
None Moderate
Marked
Cerebralfunction
Agitated
Nl
Coma
Depressed
WoodDW.AmJDisChild1972;123(3):2278
Absent
decreased
Statusasthmaticus :Assessment
ChestXRay
Notroutinelyindicated
Exceptions:
Patientisintubated/ventilated
Suspectedbarotrauma
Suspectedpneumonia
Othercausesforwheezingarebeingsuspected
Statusasthmaticus :Assessment
ABG
Earlystatusasthmaticus:hypoxemia,
hypocarbia
Late:hypercarbia
Decisiontointubateshouldnotdependon
ABG,butonclinicalassessment
FrequentABGsarecrucialintheventilated
asthmatic
Statusasthmaticus
StatusAsthmaticusinChildren
Epidemiology
Pathophysiology
Presentationandassessment
Treatment
Conventional
General,agonists,steroids,anticholinergics
Advanced
Mechanicalventilation,ketamine,inhalationalanesthetics
Unusual/Unproven
Theophylline,magnesium,LTRAs,heliox,bronchoscopy
Statusasthmaticus :Treatment
Oxygen
Deliverhighflowoxygen,as
severeasthmacausesV/Q
mismatch(shunt)
Oxygenwillnotsuppressrespiratorydrivein
childrenwithasthma
SchiffM.ClinChestMed1980;1(1):859
Statusasthmaticus :Treatment
Fluid
JudicioususeofIVfluidnecessary
Mostasthmaticsaredehydratedon
presentationsrehydratetoeuvolemia
Overhydrationmayleadtopulmonary
edema
SIADHmaybecommoninsevereasthma
BakerJW.MayoClinProc1976;51(1):314
Statusasthmaticus :Treatment
Antibiotics
Mostinfectionsprecipitatingasthma
areviral
Antibioticsarenotroutinely
indicated
JohnstonSL.PediatrPulmonolSuppl1999;18:1413
Statusasthmaticus :Treatment
Agonists
receptoragonistsstimulate 2receptorsonbronchialsmoothmuscleandmediatemusclerelaxation
Epinephrine
Isoproterenol
Terbutaline
Albuterol
Significant1cardiovascular
effects
Relatively2selective
Statusasthmaticus :Treatment
Agonists
Lessthan10%ofnebulizeddrugreachthe
lungunderidealconditions
BisgaardH.JAsthma1997;34(6):44367
Drugdeliverydependson
Breathingpattern
Tidalvolume
Nebulizertypeandgasflow
Statusasthmaticus :Treatment
Agonists
Deliveryofnebulizeddrug
Onlyparticles
between m are
depositedinalveoli
Correctgasflowrateis
crucial
Mostdevicesrequire1012
L/mingasflowtogenerate
correctparticlesize
Statusasthmaticus :Treatment
Agonists
Continuousnebulizationissuperiorto
intermittentnebulization
Morerapidimprovement
Morecosteffective
Morepatientfriendly
PapoMC.CritCareMed1993;21:147986
AckermanAD.CritCareMed1993;21:14224
Statusasthmaticus :Treatment
Agonists
Dosage
Intermittentnebulization
2.55mg(0.51mlof0.5%solution),dilutewithNS
to3ml
Prediluted:2.5mgas3mlof0.083%solution
Highdose:useuptoundiluted5%solution
Continuousnebulization
440mg/hr
Highdose:uptoundiluted5%solution( 150mg/hr)
Statusasthmaticus :Treatment
Agonists
IntravenousAgonist
Considerforpatientswithsevereairflow
limitationwhoremainunresponsiveto
nebulizedalbuterol
Terbutalineisi.v.agonistofchoiceinUS
Dosage:0.110 g/kg/min
StephanopoulosDE.CritCareMed1998;26(10):17448
Statusasthmaticus :Treatment
Agonists
Sideeffects
Tachycardia
Agitation,tremor
Hypokalemia
Statusasthmaticus :Treatment
Agonists
Cardiacsideeffects
Myocardialischemiaknowntooccurwithi.v.
isoproterenol
Nosignificantcardiovasculartoxicitywithi.v.
terbutaline(prospectivestudyinchildrenwith
severeasthma)
ChiangVW.JPediatr2000;137(1):737
Tachycardia(andtremor)showtachyphylaxis,
bronchodilationdoesnot
LipworthBJ.AmRevRespirDis1989;140(3):58692
Statusasthmaticus :Treatment
Steroids
Asthmaisaninflammatorydisease
Steroidsareamandatoryelementoffirst
linetherapyregimen(fewexceptionsonly)
140
120
F E V 1%
100
80
Steroids
Placebo
60
40
20
Effectofi.v.
hydrocortisone
vs.placebo
0
-20
-5
12
18
24
Hours
FantaCH:AmJMed1983;74:845
Statusasthmaticus :Treatment
Steroids
Hydrocortisone48mg/kgx1,then24
mg/kgq6
Methylprednisolone2mg/kgx1,then0.51
mg/kgq46
Statusasthmaticus :Treatment
Steroids
Significantsideeffects
Hyperglycemia
Hypertension
Acutepsychosis
Unusualorunusuallysevereinfections
Steroidscontraindicatedwithactiveor
recentexposuretochickenpox
Allergicreaction
Reportedwithmethylprednisolone,
hydrocortisoneandprednisone*
*VanpeeD.AnnEmergMed1998;32(6):754.KammGL.AnnPharmacother1999;33(4):45160.
SchonwaldS.AmJEmergMed1999;17(6):5835.JudsonMA.Chest1995;107(2):5635.
Statusasthmaticus :Treatment
AnticholinergicsIpratropium
Quaternaryatropinederivative
Notabsorbedsystemically
Thusminimalcardiaceffects
(Butyouwillfindafixed/dilatedpupilifthenebulizermaskslipsover
aneye!)
Statusasthmaticus :Treatment
Anticholinergics
ChangeinFEV1issignificantlygreaterwhen
ipratropiumwasaddedtoagonists(199adults)
RebuckAS:AmJMed1987;82:59
Highlysignificantimprovementinpulmonary
functionwhenipratropiumwasaddedto
albuterol(128children).Sickestasthmatics
experiencedgreatestimprovement
SchuhS.JPediatr1995;126(4):63945
Statusasthmaticus :Treatment
Ipratropium
DoseResponseCurveinChildren(n=19,age11
17yrs)
Average increase in FEV1 (over 4 hrs)
0.4
0.3
0.2
0.1
0
7.5
25
75
Dose (micrograms)
DavisA:JPediatr1984;105:1002
250
Statusasthmaticus :Treatment
Ipratropium
Nebulize250500 gevery46hours
SchuhS.JPediatr1995;126(4):63945
GoodmanandGilman's.9thed.NewYork:McGrawHill;1996
Statusasthmaticus :Treatment
Intubation,Ventilation
Absoluteindications:
Cardiacorrespiratoryarrest
Severehypoxia
Rapiddeteriorationinmentalstate
Respiratoryacidosisdoesnotdictate
intubation
Statusasthmaticus :Treatment
Whyhesitatetointubatethe
asthmaticchild?
Trachealforeignbody
aggravatesbronchospasm
Positivepressureventilation
increasesriskofbarotrauma
andhypotension
TuxenDV.AmRevRespirDis1987;136(4):8729
>50%ofmorbidity/mortalityduringsevereasthma
occursduringorimmediatelyafterintubation
ZimmermanJL.CritCareMed1993;21(11):172730
Statusasthmaticus :Treatment
Intubation
Preoxygenate,decompressstomach
Sedate(considerketamine)
Neuromuscularblockade(mayavoid
largeswingsinairway/pleuralpressure)
Rapidorotrachealintubation(consider
cuffedtube)
Statusasthmaticus :Treatment
Immediatelyafterintubation
Expecthypotension,circulatorydepression
Allowlongexpiratorytime
Avoidoverzealousmanualbreaths
Considervolumeadministration
Considerpneumothorax
Considerendotrachealtubeobstruction(++
secretions)
Statusasthmaticus :Treatment
Mechanicalventilation
Positivepressureventilationworsens
hyperinflation/riskofbarotrauma
Thoughtfulstrategiesinclude:
Pressurelimitedventilation,TV812ml/kg,shortT i,rate
812/min(permissivehypercapnia)
CoxRG.PediatrPulmonol1991;11(2):1206
PressuresupportventilationusingPS=2030cmH 2O(may
decreasehyperinflationbyallowingactiveexhalation)
WetzelRC.CritCareMed1996;24(9):16035
Statusasthmaticus :Treatment
Ketamine
Dissociativeanestheticwithstrong
analgesiceffect
Directbronchodilatingaction
Usefulforinduction(2mg/kgi.v.)aswellas
continuousinfusion(0.52mg/kg/hr)
Inducesbronchorrhea,emergencereaction
Statusasthmaticus :Treatment
Inhalationalanesthetics
Halothane,isofluranehavebronchodilating
effect
Halothanemaycausehypotension,
dysrhythmia
Requiresscavengingsystem,continuous
gasanalysis
Statusasthmaticus :Treatment
Theophylline
Roleinchildrenwithsevereasthma
remainscontroversial
Narrowtherapeuticrange
Highriskofseriousadverseeffects
Mechanismofeffectinasthmaremains
unclear
Statusasthmaticus :Treatment
Theophylline
Mayhavearoleinselected,criticallyillchildren
withasthmaunresponsivetoconventional
therapy:
Randomized,placebocontrolled,blindedtrial(n=163)inchildrenwith
severestatusasthmaticus
TheophyllinegrouphadgreaterimprovementinPFTsandO 2saturation
Nodifferenceinlength
FEV1(%)
ofPICUstay
60
Theophyllinegrouphadsignifi
50
cantlymoreN/V
40
Placebo
Theophylline
30
YungM.ArchDisChild1998;79(5):40510.
20
10
0
Prior
6hr
12hr
24hr
Statusasthmaticus :Treatment
Magnesium
Smoothmusclerelaxationbyinhibitionof
calciumuptake(=bronchodilator)
Dosagerecommendation:2575mg/kgi.v.
over20minutes
Statusasthmaticus :Treatment
Magnesium
Severalanecdotalreports
Onlyonerandomizedpediatrictrial
Randomized,placebocontrolled,blindedtrial(n=31)inchildren
withacuteasthmainER(MgSO425mg/kgi.v.for20min)
Magnesiumgrouphadsignificantlygreaterimprovementin
60
FEV1/PEFR/FVC
Magnesiumgroupmorelikely
50
40
tobedischargedhome
30
Noadverseeffects
20
CiaralloL.JPediatr1996;129(6):80914.
10
0
50min
80min
110min
Placebo
Magnesium
Statusasthmaticus
Leukotrienereceptorantagonists
(LTRAs)
Asthmaticchildrenhaveincreased
leukotrienelevels(blood,urine)during
anattack.Levelfallsasattackresolves
SampsonAP.AnnNYAcadSci1991;629:4379.
LTRAadministrationisassociatedwith
improvementinlungfunctionin
asthmatics
GaddyJN.AmRevRespirDis1992;146(2):35863.
Statusasthmaticus
LTRAs
Steroidadministrationtoasthmaticshas
littleeffectonleukotrienelevels
O'ShaughnessyKM.AmRevRespirDis1993;147(6Pt1):14726.
Thus,LTRAsmayofferadditionalbenefits
toasthmaticsonsteroids
ReissTF.ArchInternMed1998;158(11):121320.
Statusasthmaticus
IntravenousLTRAsinmoderate
tosevereasthma
Asingledoseofi.v.
montelukast
(Singulair)was
associatedwith
significant
improvementinlung
functioncomparedto
standardtherapy
CamargoCA,Jr.AmJRespirCritCareMed2003;167(4):52833.
Statusasthmaticus
LTRAsRemainingquestions
Willtheyofferaddedbenefitintheacute,severe
asthmaticchildalreadyonagonists,steroids,
anticholinergics?
Morerapidimprovementinlungfunction/clinicalscore?
Reduced/shortenedhospitalization?
FewerPICUadmissions?
Cost?
Adverseeffects?
Statusasthmaticus :Treatment
HeliumOxygen(Heliox)
Heliumlowersgasdensity(ifatleast
60%heliumfraction)
Reducesresistanceduringturbulentflow
Rendersturbulentflowlesslikelyto
occur
Statusasthmaticus :Treatment
Heliox
Anecdotalreportsofimprovedrespiratory
mechanicsinnonintubatedandintubated
asthmaticchildren
Prospective,randomized,blindedcrossover
studyofhelioxinnonintubatedchildren
withsevereasthma(n=11):noeffecton
respiratorymechanicsorasthmascore
CarterER.Chest1996;109(5):125661.
Statusasthmaticus :Treatment
Heliox
Heliumoxygen(80:20)decreasedpulsus
paradoxusandincreasedPEFRina
controlledtrialofadultpatients
ManthousCA.AmJRespirCritCareMed1995,151:310314
Helioxmayworsendynamichyperinflation
MadisonJM.Chest1995,107:597598
Statusasthmaticus :Treatment
Bronchoscopy,bronchial
lavage
Markedmucuspluggingmayrender
bronchodilatingandantiinflammatory
therapyineffective
Plasticbronchitishasbeendescribedin
asthmaticchildren
Combinedbronchoscopy/lavagehasbeen
usedindesperatelyillasthmaticchildren
Statusasthmaticus
Summary
Severeasthmainchildrenisincreasinginprevalence
andmortality
Aggressivetreatmentwithagonist,steroidsand
anticholinergiciswarrantedeveninthesickappearing
child
Avoidintubationifpossible
Mechanicalventilationwillworsenbronchospasmand
hyperinflation
Uselowmorbidityapproachtomechanicalventilation
Statusasthmaticus
Prevention
Stepstowardprevention
1.
Identifypatientsasatrisk
2.
Tellthemabouttheirrisks
3.
Organizetreatmentplan
4.
Facilitateaccesstocontinuedcare
Statusasthmaticus
CaseScenario(1)
A6yoblackmalewithprevioushistoryofasthmais
admittedwithsevererespiratorydistress.Heiswheezing,
RRis40/min,HR145/min.Hesitsupright,leansforward,
hasretractionsandlooksveryanxious.Hecorrectlytells
youhisnameandphone#,buthastotakeabreathafter
everyfewwords.
Discussyourinitialtherapeuticapproach.
Statusasthmaticus
CaseScenario(2)
Whichofthefollowingaremandatoryinthischildwithsevere
asthma?
(Youmaychosenone,morethanoneorall)
Arterialbloodgasanalysis(todetectonsetofrespiratory
acidosis)
Continuouspulseoximetry
Chestradiograph(toruleoutpneumomediastinum/thorax)
Frequentdeterminationofpeakexpiratoryflowrate
Whitebloodcellcountwithdifferential(toassessneedfor
antibiotics)
Statusasthmaticus
CaseScenario(3)
Givenhiscurrentpresentation:doesthischildneedtobe
intubatedandmechanicallyventilated?
Discussindicationsforintubation/mechanicalventilation
inthechildwithseverestatusasthmaticus.
Statusasthmaticus
CaseScenario(4)
Whennebulizingdrugsduringstatusasthmaticus,thefollowing
statementaboutgasflowratesisCORRECT:
A.
B.
C.
D.
Thehigherthegasflowratethroughthenebulizer,the
moreparticleswillbedepositedinthepatientsalveolar
space
Mostdevicesrequireagasflowrateof1012L/minto
generateoptimalparticlesize
Gasflowratesabove5L/minshouldbeavoidedto
maintainlaminarflowinthenebulizeroutput
Thenebulizerdeviceshouldnotbedrivenby100%oxygen
Statusasthmaticus
CaseScenario(5)
Inadditiontoadministrationofcontinuouslynebulizedbeta
agonistandintermittentanticholinergicagonist,whichofthe
followingisalmostmandatory?Discussprosandconsforeach.
A.
B.
C.
D.
E.
Intravenousbolusofaminophylline,followedby
infusion
Intravenouscorticosteroid
Intravenousbroadspectrumantibiotic
Intravenousbetaagonistinfusion
Inhaledheliumoxygenmixture
Statusasthmaticus
CaseScenario(6)
After3hoursoftherapyinthePICU,includinghighdose
continuousalbuterol,intermittentipratropium,I.v.
methylprednisoloneaswellastwoinfusionsofmagnesium
sulfate,thechildbecomesobtunded.HisO2saturations
begintodropbelow85%.Isthisanindicationfor
intubation/mechanicalventilation?
Ifso,describeyourapproachtointubatingthischild.
Howtoprepare?Drugs?ETTsize,route?Anticipatedproblems/
complications?Initialpatternofventilation?
Statusasthmaticus
CaseScenario(7)
Afteryouconnectthechildtotheventilator,hedevelops
markedarterialhypotension.
Whatisyourdifferentialdiagnosis?
Whatshouldyoudo?
Statusasthmaticus
SuggestedReading(part1):
1. LaitinenLA,HeinoM,LaitinenA,etal.Damageofairwayepitheliumandbronchialreactivityinpatientswithasthma.
AmRevRespirDis1985;131(4):599606.
2. BeakesDE.Theuseofanticholinergicsinasthma.JAsthma1997;34(5):35768.
3. BarnesPJ.Betaadrenergicreceptorsandtheirregulation.AmJRespirCritCareMed1995;152(3):83860.
4. MiroA,PinskyM.CardiopulmonaryInteractions.In:FuhrmanB,ZimmermanJ,editors.PediatricCriticalCare.
Seconded.St.Louis:Mosby;1998.p.25060.
5. StalcupSA,MellinsRB.Mechanicalforcesproducingpulmonaryedemaandacuteasthma.NEnglJMed
1977;297(11):5926.
6. RebuckAS,PengellyLD.Developmentofpulsusparadoxusinthepresenceofairwayobstruction.NEnglJMed
1973;288(2):669.
7. PapoMC,FrankJ,ThompsonAE.Aprospective,randomizedstudyofcontinuousversusintermittentnebulized
albuterolforseverestatusasthmaticusinchildren.CritCareMed1993;21:147986.
8. KatzRW,KellyHW,CrowleyMR,etal.Safetyofcontinuousnebulizedalbuterolforbronchospasmininfantsand
children[publishederratumappearsinPediatrics1994Feb;93(2):A28].Pediatrics1993;92(5):6669.
9. SchuhS,JohnsonDW,CallahanS,etal.Efficacyoffrequentnebulizedipratropiumbromideaddedtofrequenthighdose
albuteroltherapyinseverechildhoodasthma.JPediatr1995;126(4):63945.
10. FantaCH,RossingTH,McFaddenER.Glucocorticoidsinacuteasthma:Acriticalcontrolledtrial.AmJMed
1983;74:84551.
Statusasthmaticus
SuggestedReading(part2):
11. KleinGitelmanMS,PachmanLM.Intravenouscorticosteroids:adversereactionsaremorevariablethan
expectedinchildren.JRheumatol1998;25(10):19952002.
12. StephanopoulosDE,MongeR,SchellKH,etal.Continuousintravenousterbutalineforpediatricstatus
asthmaticus.CritCareMed1998;26(10):17448.
13. ChiangVW,BurnsJP,RifaiN,etal.Cardiactoxicityofintravenousterbutalineforthetreatmentofsevere
asthmainchildren:aprospectiveassessment.JPediatr2000;137(1):737.
14. CiaralloL,SauerAH,ShannonMW.Intravenousmagnesiumtherapyformoderatetoseverepediatric
asthma:resultsofarandomized,placebocontrolledtrial.JPediatr1996;129(6):80914.
15. PabonH,MonemG,KissoonN.Safetyandefficacyofmagnesiumsulfateinfusionsinchildrenwithstatus
asthmaticus.PediatrEmergCare1994;10:2003.
16. YungM,SouthM.Randomisedcontrolledtrialofaminophyllineforsevereacuteasthma.ArchDisChild
1998;79(5):40510.
17. TuxenDV,LaneS.Theeffectsofventilatorypatternonhyperinflation,airwaypressures,andcirculationin
mechanicalventilationofpatientswithsevereairflowobstruction.AmRevRespirDis1987;136(4):8729.
18. WetzelRC.Pressuresupportventilationinchildrenwithsevereasthma.CritCareMed1996;24(9):16035.
19. IbsenLM,BrattonSL.Currenttherapiesforsevereasthmaexacerbationsinchildren.NewHoriz
1999;7(3):31225.
20. WernerHA.Statusasthmaticusinchildren:areview.Chest2001;119(6):191329.